← Browse by Condition
Medical Condition
post essential thrombocythemia myelofibrosis
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT06351631 Phase 3
Recruiting
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Enrollment
400 pts
Location
United States, Austr...
Sponsor
Merck Sharp & Dohme LLC
NCT06976918
Recruiting
Registry Platform Myelofibrosis and Anemia
Enrollment
200 pts
Location
Germany
Sponsor
iOMEDICO AG